2025 - Passed
Tennessee S.B.2011/H.B.2903
  • Prevents opioids from being preferred over a non-opioid pain medication on TennCare's preferred drug list and makes a non-opioid available immediately upon FDA-approval.
  • Requires state Medicaid departments to ensure prescribers and hospitals are reimbursed for providing non-opioid medications.
  • Prohibits health insurers from denying coverage of a non-opioid prescription drug in favor of an opioid, when prescribed.
Medicaid Parity
Read House BillRead Senate Bill
2025 - Introduced
Utah S.B. 331
  • Prohibits Medicaid and health insurers from imposing more restrictive or extensive prescription drug utilization management practices for a non-opioid drug than the least restrictive or extensive practice applicable to any opioid.
  • Requires that if Utah Department of Health and Human Services funding is available, pamphlets about opiates should include information about non-opioid drug alternatives.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
Virginia H.B.1765
  • Prohibits health insurers from imposing cost-sharing, prior authorization, step therapy, or other coverage limitations on a covered FDA-approved non-opioid drug.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2024 - Passed
Virginia H.B.699
  • Provides that the Virginia Boards of Medicine, Optometry, Dentistry, and Medicine and Nursing update regulations to require prescribers to document and discuss risks with patients.
Provider Education
Read Bill
2025 - Introduced
Virginia S.B.800
  • Ensures that no non-opioid approved by the FDA shall be disadvantaged or discouraged relative to opioids, including through prior authorization or step therapy.
Medicaid Parity
Read Bill
2024 - Introduced
Washington H.B.1034
  • Prohibits health insurers from imposing restrictive practices that disadvantage or discourage the use of non-opioid drugs for the treatment of pain relative to opioid drugs.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
West Virginia H.B. 3070/S.B. 628
  • Prohibits West Virginia's Medicaid and commercial health insurance formularies or preferred drug lists from disadvantaging or discouraging a non-opioid drug with respect to coverage of an opioid drug, including through more restrictive coverage criteria, utilization management, or cost sharing.
  • Requires the West Virginia Bureau of Public Health develop educational materials about non-opioid alternatives for the treatment of acute pain.
Medicaid ParityState Regulated Commercial Parity
Read House BillRead Senate Bill